CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Genomic Vision Sa Company Snapshot
Genomic Vision Sa operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Genomic Vision Sa with three other miscellaneous service companies in Europe: Arix Bioscience Plc of the United Kingdom (2017 sales of £1.86 million [US$2.59 million] ), Fusion Antibodies PLC of the United Kingdom (£1.91 million [US$2.67 million] of which 100% was Pharmaceutical), and Genovis AB which is based in Sweden (22.89 million Swedish Kronor [US$2.69 million] ).

Sales Analysis. During the year ended December of 2017, sales at Genomic Vision Sa were 2.14 million Euro (US$2.61 million). This is an increase of 36.1% versus 2016, when the company's sales were 1.57 million Euro. Despite this increase, sales are still below the level achieved in 2015, when Genomic Vision Sa reported sales of 2.36 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Genomic Vision Sa
  Stock Performance Chart for Genomic Vision Sa
 
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 2.06
(Figures in Euro)
1 Week -4.4%   13 Weeks -16.1%  
4 Weeks -34.7%   52 Weeks -22.2%  
 
Genomic Vision Sa Key Data:
  Ticker: GV Country: France
  Exchanges: PAR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 2,141,000
(Year Ending Jan 2018).
Employees: 35
  Currency: Euro Market Cap: 10,174,307
  Fiscal Yr Ends: December Shares Outstanding: 4,951,001
  Share Type: Ordinary Closely Held Shares: 1,223,043
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.